CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

KOD Begins Late-Stage Study of KSI-501 in Diabetic Macular Edema

Phase 3KSI-501Positive
AI Analysis

Summary

KOD announced the initiation of a late-stage (Phase 3) clinical study evaluating KSI-501 for the treatment of diabetic macular edema.

Clinical Trial Data

Phase

Phase 3

Importance:5/10
Sentiment:
0.30
clinical trialophthalmologydiabetic macular edemalate-stage development
Related Companies

Read the original article

Published by yahoo_finance on August 11, 2026 3:15 PM

Read Original